We lead initiatives across the Asia-Pacific, working to solve new challenges to achieving the elimination of malaria. Our work focuses on identifying the spread of drug resistant parasites and developing new strategies to treat them. More recently studies have focussed on improving the use of the drug primaquine to kill the dormant stages of Plasmodium vivax. These trials are changing the way many countries are delivering antimalarial policy.